NO20064232L - Alfa.emitterende hydroksyapatittparikler - Google Patents

Alfa.emitterende hydroksyapatittparikler

Info

Publication number
NO20064232L
NO20064232L NO20064232A NO20064232A NO20064232L NO 20064232 L NO20064232 L NO 20064232L NO 20064232 A NO20064232 A NO 20064232A NO 20064232 A NO20064232 A NO 20064232A NO 20064232 L NO20064232 L NO 20064232L
Authority
NO
Norway
Prior art keywords
hydroxyapatite particles
alpha
alpha emitting
emitting hydroxyapatite
emitting radionuclide
Prior art date
Application number
NO20064232A
Other languages
English (en)
Inventor
Gro Salberg
Roy Larsen
Original Assignee
Algeta As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2005/000616 external-priority patent/WO2005079867A2/en
Application filed by Algeta As filed Critical Algeta As
Publication of NO20064232L publication Critical patent/NO20064232L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Confectionery (AREA)

Abstract

Den foreliggende oppfinnelsen tilveiebringer hydroksyapatitt (HA) inkorporerende en alfaemitterende radionukhde eller en in vivo generator for en alfaemitterende radionuklide. Oppfinnelsen tilveiebringer videre metoder for fremstilling av slik HA, farmasøytiske sammensetninger omfattende HA'en og metoder for medisinsk behandling av cancerøs eller ikke-cancerøs sykdom inkludert administrering av HA'en eller sammensetninger derav.
NO20064232A 2004-02-20 2006-09-19 Alfa.emitterende hydroksyapatittparikler NO20064232L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0403856.8A GB0403856D0 (en) 2004-02-20 2004-02-20 Composition
PCT/GB2005/000616 WO2005079867A2 (en) 2004-02-20 2005-02-18 Alpha-emitting hydroxyapatite particles

Publications (1)

Publication Number Publication Date
NO20064232L true NO20064232L (no) 2006-09-19

Family

ID=32040119

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064232A NO20064232L (no) 2004-02-20 2006-09-19 Alfa.emitterende hydroksyapatittparikler

Country Status (13)

Country Link
JP (1) JP5214884B2 (no)
KR (2) KR20070038030A (no)
CN (1) CN1972720B (no)
AT (1) ATE544492T1 (no)
DK (1) DK1735013T3 (no)
ES (1) ES2382041T3 (no)
GB (1) GB0403856D0 (no)
IL (1) IL177354A (no)
NO (1) NO20064232L (no)
NZ (1) NZ549080A (no)
PT (1) PT1735013E (no)
TW (1) TWI347194B (no)
ZA (1) ZA200606728B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3111959T3 (pl) * 2015-07-03 2018-03-30 Oncoinvent As Radioterapeutyczne cząstki i zawiesiny
US20170065731A1 (en) * 2015-09-06 2017-03-09 Medical Theranostics Inc. Method, Apparatus, and System for Radiation Therapy
CN106344927A (zh) * 2016-09-27 2017-01-25 大连理工大学 叶酸修饰的载药羟基磷灰石及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2119778T3 (es) * 1990-12-21 1998-10-16 Mallinckrodt Medical Inc Particulas en marcaje por radionucleidos utilizadas en sinovectomia por radiacion.
US6060037A (en) * 1993-10-26 2000-05-09 Thomas Jefferson University Compositions that specifically bind to colorectal cancer cells and methods of using the same
WO1997001304A1 (en) * 1995-06-29 1997-01-16 Mallinckrodt Medical, Inc. Radiolabeled apatite particles containing a paramagnetic ion
AU772755B2 (en) * 1999-10-18 2004-05-06 Ferx Incorporated Magnetic targeted carrier composed of iron and porous materials for the targeted delivery of biologically active agents
JP3836444B2 (ja) * 2002-05-30 2006-10-25 独立行政法人科学技術振興機構 ハイドロキシアパタイト複合体およびその製造方法、ならびに、それを用いた医療用材料

Also Published As

Publication number Publication date
ATE544492T1 (de) 2012-02-15
KR101165518B1 (ko) 2012-07-16
ZA200606728B (en) 2007-12-27
ES2382041T3 (es) 2012-06-04
IL177354A0 (en) 2006-12-10
GB0403856D0 (en) 2004-03-24
DK1735013T3 (da) 2012-05-21
JP5214884B2 (ja) 2013-06-19
IL177354A (en) 2013-04-30
TW200536558A (en) 2005-11-16
CN1972720A (zh) 2007-05-30
JP2007528373A (ja) 2007-10-11
NZ549080A (en) 2011-01-28
CN1972720B (zh) 2010-07-07
KR20100060029A (ko) 2010-06-04
KR20070038030A (ko) 2007-04-09
PT1735013E (pt) 2012-05-08
TWI347194B (en) 2011-08-21

Similar Documents

Publication Publication Date Title
EA200601524A1 (ru) Альфа-излучающие частицы гидроксиапатита
LTPA2017009I1 (lt) Brutono tirozinkinazės inhibitoriai
IL176007A0 (en) Antibodies specific to c35 and pharmaceutical compositions containing the same
SG166775A1 (en) Combinations and modes of administration of therapeutic agents and combination therapy
SI1472541T1 (sl) Prikazovalni agensi in postopek prikazovanja naaladase ali psma
CY1112387T1 (el) Θεραπευτικη συνθεση περιεχουσα τουλαχιστον ενα παραγωγο της πυρρολοβενζοδιαζεπινης και φλουδαραβινη
CY1112055T1 (el) Συνθεσεις και μεθοδοι για την διαγνωση και θεραπευτικη αγωγη ογκου πνευμονα
HK1120427A1 (en) Anti-glypican-3 antibody
HK1130186A1 (en) Phospholipid analogue for the in vivo diagnosis of cancers
DE602005010788D1 (de) Pharmazeutische Zusammensetzungen zur sicheren Verabreichung von bei der Behandlung von Drogenabhängigkeit verwendeten Arzneimitteln
IL189104A (en) Pharmaceutical preparation containing lasalazide or sodium balasalazide for use in the treatment of gastrointestinal disorders.
CY1110369T1 (el) Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη
CY1107231T1 (el) Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης
NO20064232L (no) Alfa.emitterende hydroksyapatittparikler
TW200509863A (en) Irradiation device for medical use
ECSP045054A (es) Composicion farmaceutica para utilizarse para el tratamiento de malignidades, que comprende una combinacion de bisfosfonatos, un inhibidor de cox-2 y un taxol
WO2003076651A3 (en) Cancer associated araf1 protein kinase and its uses
EA200600987A1 (ru) Применение сирамезина в лечении злокачественных опухолей

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application